Dishman Carbogen Amcis planning to invest $50 million in France to set up new facility

21 Oct 2021 Evaluate

Dishman Carbogen Amcis (DCAL) is planning to invest $ 50 million in France to set up a new facility for manufacturing formulated products, mainly in the form of parenterals. The new facility would begin commercial production from January 2023 with two manufacturing lines.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×